Metini Janyasupab

Title: Metini Janyasupab: Innovator in Cancer Detection

Introduction

Metini Janyasupab is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in cancer detection. His innovative work focuses on the detection of lysyl oxidase-like 2 protein (LOXL2), which is associated with breast cancer.

Latest Patents

Metini Janyasupab holds a patent for a "System and method for detecting lysyl oxidase-like 2 protein (LOXL2) and breast cancer." This detection system is designed to determine LOXL2 levels in bodily samples. It includes at least one reaction solution that generates hydrogen peroxide in combination with LOXL2. The reaction solution contains lysine, which can be oxidatively deaminated by LOXL2 to produce α-aminoadipic-δ-semialdehyde (allysine) and hydrogen peroxide.

Career Highlights

Metini Janyasupab is affiliated with Case Western Reserve University, where he continues to advance his research in cancer detection technologies. His work has the potential to improve early diagnosis and treatment options for breast cancer patients.

Collaborations

He collaborates with esteemed colleagues, including Chung-Chiun Liu and Yuan Zhang, who contribute to his research efforts and enhance the impact of his innovations.

Conclusion

Metini Janyasupab's contributions to cancer detection through his innovative patent demonstrate his commitment to advancing medical technology. His work is vital in the ongoing fight against breast cancer, and it highlights the importance of research in improving patient outcomes.